Edna Kott

952 total citations
58 papers, 747 citations indexed

About

Edna Kott is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Edna Kott has authored 58 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Edna Kott's work include Myasthenia Gravis and Thymoma (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Alzheimer's disease research and treatments (4 papers). Edna Kott is often cited by papers focused on Myasthenia Gravis and Thymoma (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Alzheimer's disease research and treatments (4 papers). Edna Kott collaborates with scholars based in Israel, United States and Germany. Edna Kott's co-authors include M. Huberman, Benjamin Sredni, F. Shalit, Chaya Brodie, Allyn H. Rule, B. Bornstein, I. Roth‐Deri, Boris A. Gutman, E Livni and U. Sandbank and has published in prestigious journals such as The Lancet, Blood and Neurology.

In The Last Decade

Edna Kott

54 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edna Kott Israel 17 217 183 163 146 115 58 747
Yung-Fu Wu Taiwan 20 182 0.8× 139 0.8× 77 0.5× 386 2.6× 105 0.9× 33 1.0k
Hong‐Qi Li China 17 192 0.9× 148 0.8× 102 0.6× 187 1.3× 37 0.3× 69 1.1k
Halina Bartosik-Psujek Poland 21 129 0.6× 187 1.0× 212 1.3× 271 1.9× 93 0.8× 116 1.3k
Vince Fazio United States 8 42 0.2× 111 0.6× 145 0.9× 211 1.4× 41 0.4× 9 552
Xu Yi China 14 163 0.8× 105 0.6× 101 0.6× 219 1.5× 27 0.2× 35 590
Kimberly E. Hawkins United States 10 115 0.5× 427 2.3× 117 0.7× 330 2.3× 31 0.3× 16 1.1k
Xiaojuan Liu China 16 226 1.0× 333 1.8× 76 0.5× 261 1.8× 30 0.3× 55 1.0k
Meaghan Roy-O’Reilly United States 18 154 0.7× 401 2.2× 209 1.3× 273 1.9× 36 0.3× 24 1.1k
Les Shaw United States 10 434 2.0× 123 0.7× 135 0.8× 157 1.1× 19 0.2× 18 1.0k
Pernilla Svedin Sweden 17 96 0.4× 286 1.6× 131 0.8× 253 1.7× 33 0.3× 36 1.2k

Countries citing papers authored by Edna Kott

Since Specialization
Citations

This map shows the geographic impact of Edna Kott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edna Kott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edna Kott more than expected).

Fields of papers citing papers by Edna Kott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edna Kott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edna Kott. The network helps show where Edna Kott may publish in the future.

Co-authorship network of co-authors of Edna Kott

This figure shows the co-authorship network connecting the top 25 collaborators of Edna Kott. A scholar is included among the top collaborators of Edna Kott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edna Kott. Edna Kott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flechter, Shlomo, Edna Kott, Bettina Steiner‐Birmanns, Puiu Nisipeanu, & Amos D. Korczyn. (2002). Copolymer 1 (Glatiramer Acetate) in Relapsing Forms of Multiple Sclerosis: Open Multicenter Study of Alternate-Day Administration. Clinical Neuropharmacology. 25(1). 11–15. 9 indexed citations
2.
Miller, Mark A., B. Shohat, Dina Ron, et al.. (1999). Transmission of HTLV-I to Rats via Peripheral Blood Mononuclear Cells and Serum From a Patient With HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) With Amyotrophic Lateral Sclerosis (ALS)-Like Features. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(4). 403–407. 4 indexed citations
3.
Kott, Edna, Asia Sikora Kessler, & S Biran. (1997). 3-31-14 Optic neuritis in multiple sclerosis patients treated with Copaxone® (Glatiramer acetate for injection). Journal of the Neurological Sciences. 150. S186–S186. 1 indexed citations
4.
Kesler, Anat, et al.. (1996). [Post-shock optic neuropathy].. PubMed. 131(9). 305–7, 374.
5.
Kesler, Anat, I Pomeranz, M. Huberman, Ben Novis, & Edna Kott. (1996). Cerebral venous thrombosis and chronic active hepatitis as part of the antiphospholipid syndrome. Postgraduate Medical Journal. 72(853). 690–692. 18 indexed citations
6.
Huberman, M., et al.. (1995). IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease. Journal of the Neurological Sciences. 130(2). 161–164. 53 indexed citations
7.
Shalit, F., Benjamin Sredni, Chaya Brodie, Edna Kott, & M. Huberman. (1995). T Lymphocyte Subpopulations and Activation Markers Correlate with Severity of Alzheimer's Disease. Clinical Immunology and Immunopathology. 75(3). 246–250. 79 indexed citations
8.
Shalit, F., et al.. (1994). Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neuroscience Letters. 174(2). 130–132. 45 indexed citations
9.
Huberman, M., F. Shalit, I. Roth‐Deri, et al.. (1994). Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage. Journal of Neuroimmunology. 52(2). 147–152. 90 indexed citations
10.
Huberman, M., F. Shalit, I. Roth‐Deri, et al.. (1993). Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis. Journal of the Neurological Sciences. 118(1). 79–82. 12 indexed citations
11.
Kott, Edna, Talia Hahn, M. Huberman, Stanley Levin, & Ami Schattner. (1990). Interferon System and Natural Killer Cell Activity in Myasthenia Gravis. QJM. 76(281). 951–60. 11 indexed citations
12.
Shapiro, Mia, et al.. (1984). Gonadotropin, prolactin and TSH secretion in patients with myasthenia gravis. Journal of Endocrinological Investigation. 7(6). 579–583. 5 indexed citations
13.
Radwan, Henryk, et al.. (1982). EEG in Cerebrotendinous Xanthomatosis (CTX). Clinical Electroencephalography. 13(2). 89–96. 18 indexed citations
14.
Streifler, M., et al.. (1978). HLA antigens in neurolathyrism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(2). 55–7. 2 indexed citations
15.
Segal, Ricardo, et al.. (1977). Hemiballismus with lesion of the subthalamic nucleus and neuroaxonal degeneration of the homolateral substantia nigra. Annals of Neurology. 2(2). 169–172. 3 indexed citations
16.
Kott, Edna, et al.. (1975). The effect ofl-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma. Cellular and Molecular Life Sciences. 31(1). 110–111. 7 indexed citations
17.
Elizan, Teresita S., Jerome Schwartz, Edna Kott, & Britta Pedersen. (1974). Schilder's disease. Neurology. 24(5). 428–428. 3 indexed citations
18.
Kott, Edna & Allyn H. Rule. (1973). Myasthenia gravis. Neurology. 23(7). 745–745. 21 indexed citations
20.
Kott, Edna, et al.. (1966). Superficial hemosiderosis of the central nervous system. Acta Neurochirurgica. 14(3-4). 287–298. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026